Emergency Contraception in the US

Emergency Contraception in the US

The most significant recent event affecting emergency contraception actually occurred in December 2011, but reverberated throughout 2012. Since 2009, consumers aged 17 years and older were able to purchase emergency contraception without a prescription, albeit behind-the-counter. In February 2011, Teva submitted an application to the FDA requesting non-prescription access to its Plan B emergency contraception drug for those aged under 17 (competing products would remain behind-the-counter).

Euromonitor International's Emergency Contraception in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.